- •Preface and Acknowledgments
- •Contents
- •Contributors
- •1: Embryology for Urologists
- •Introduction
- •Renal Development
- •Pronephros
- •Mesonephros
- •Metanephros
- •Development of the Collecting System
- •Critical Steps in Further Development
- •Anomalies of the Kidney
- •Renal Agenesis
- •Renal Aplasia
- •Renal Hypoplasia
- •Renal Ectopia
- •Renal Fusion
- •Ureteral Development
- •Anomalies of Origin
- •Anomalies of Number
- •Incomplete Ureteral Duplication
- •Complete Ureteral Duplication
- •Ureteral Ectopia
- •Embryology of Ectopia
- •Clinical Correlation
- •Location of Ectopic Ureteral Orifices – Male (in Descending Order According to Incidence)
- •Symptoms
- •Ureteroceles
- •Congenital Ureteral Obstruction
- •Pipestem Ureter
- •Megaureter-Megacystis Syndrome
- •Prune Belly Syndrome
- •Vascular Ureteral Obstructions
- •Division of the Urogenital Sinus
- •Bladder Development
- •Urachal Anomalies
- •Cloacal Duct Anomalies
- •Other Bladder Anomalies
- •Bladder Diverticula
- •Bladder Extrophy
- •Gonadal Development
- •Testicular Differentiation
- •Ovarian Differentiation
- •Gonadal Anomalies
- •Genital Duct System
- •Disorders of Testicular Function
- •Female Ductal Development
- •Prostatic Urethral Valves
- •Gonadal Duct Anomalies
- •External Genital Development
- •Male External Genital Development
- •Female External Genital Development
- •Anomalies of the External Genitalia
- •References
- •2: Gross and Laparoscopic Anatomy of the Upper Urinary Tract and Retroperitoneum
- •Overview
- •The Kidneys
- •The Renal Vasculature
- •The Renal Collecting System
- •The Ureters
- •Retroperitoneal Lymphatics
- •Retroperitoneal Nerves
- •The Adrenal Glands
- •References
- •3: Gross and Laparoscopic Anatomy of the Lower Urinary Tract and Pelvis
- •Introduction
- •Female Pelvis
- •Male Pelvis
- •Pelvic Floor
- •Urinary Bladder
- •Urethra
- •Male Urethra
- •Female Urethra
- •Sphincter Mechanisms
- •The Bladder Neck Component
- •The Urethral Wall Component
- •The External Urethral Sphincter
- •Summary
- •References
- •4: Anatomy of the Male Reproductive System
- •Testis and Scrotum
- •Spermatogenesis
- •Hormonal Regulation of Spermatogenesis
- •Genetic Regulation of Spermatogenesis
- •Epididymis and Ductus Deferens
- •Accessory Sex Glands
- •Prostate
- •Seminal Vesicles
- •Bulbourethral Glands
- •Penis
- •Erection and Ejaculation
- •References
- •5: Imaging of the Upper Tracts
- •Anatomy of the Upper Tracts and Introduction to Imaging Modalities
- •Introduction
- •Renal Upper Tract Basic Anatomy
- •Modalities Used for Imaging the Upper Tracts
- •Ultrasound
- •Radiation Issues
- •Contrast Issues
- •Renal and Upper Tract Tumors
- •Benign Renal Tumors
- •Transitional Cell Carcinoma
- •Renal Mass Biopsy
- •Renal Stone Disease
- •Ultrasound
- •Plain Radiographs and IVU
- •Renal Cystic Disease
- •Benign Renal Cysts
- •Hereditary Renal Cystic Disease
- •Complex Renal Cysts
- •Renal Trauma
- •References
- •Introduction
- •Pathophysiology
- •Susceptibility and Resistance
- •Epidemiological Breakpoints
- •Clinical Breakpoints
- •Pharmacodynamic Parameters
- •Pharmacokinetic Parameters
- •Fosfomycin
- •Nitrofurantoin
- •Pivmecillinam
- •b-Lactam-Antibiotics
- •Penicillins
- •Cephalosporins
- •Carbapenems
- •Aminoglycosides
- •Fluoroquinolones
- •Trimethoprim, Cotrimoxazole
- •Glycopeptides
- •Linezolid
- •Conclusion
- •References
- •7: An Overview of Renal Physiology
- •Introduction
- •Body Fluid Compartments
- •Regulation of Potassium Balance
- •Regulation of Acid–Base Balance
- •Diuretics
- •Suggested Reading
- •8: Ureteral Physiology and Pharmacology
- •Ureteral Anatomy
- •Modulation of Peristalsis
- •Ureteral Pharmacology
- •Conclusion
- •References
- •Introduction
- •Afferent Signaling Pathways
- •Efferent Signaling
- •Parasympathetic Nerves
- •Sympathetic Nerves
- •Vesico-Spinal-Vesical Micturition Reflex
- •Peripheral Targets
- •Afferent Signaling Mechanisms
- •Urothelium
- •Myocytes
- •Cholinergic Receptors
- •Muscarinic Receptors
- •Nicotinic Receptors
- •Adrenergic Receptors (ARs)
- •a-Adrenoceptors
- •b-Adrenoceptors
- •Transient Receptor Potential (TRP) Receptors
- •Phosphodiesterases (PDEs)
- •CNS Targets
- •Opioid Receptors
- •Serotonin (5-HT) Mechanisms
- •g-Amino Butyric Acid (GABA) Mechanisms
- •Gabapentin
- •Neurokinin and Neurokinin Receptors
- •Summary
- •References
- •10: Pharmacology of Sexual Function
- •Introduction
- •Sexual Desire/Arousal
- •Endocrinology
- •Steroids in the Male
- •Steroids in the Female
- •Neurohormones
- •Neurotransmitters
- •Dopamine
- •Serotonin
- •Pharmacological Strategies
- •CNS Drugs
- •Enzyme-inducing Antiepileptic Drugs
- •Erectile Function
- •Ejaculatory Function
- •Premature Ejaculation
- •Abnormal Ejaculation
- •Conclusions
- •References
- •Epidemiology
- •Calcium-Based Urolithiasis
- •Uric Acid Urolithiasis
- •Infectious Urolithiasis
- •Cystine-Based Urolithiasis
- •Aims
- •Who Deserves Metabolic Evaluation?
- •Metabolic Workup for Stone Producers
- •Medical History and Physical Examination
- •Stone Analysis
- •Serum Chemistry
- •Urine Evaluation
- •Urine Cultures
- •Urinalysis
- •Twenty-Four Hour Urine Collections
- •Radiologic Imaging
- •Medical Management
- •Conservative Management
- •Increased Fluid Intake
- •Citrus Juices
- •Dietary Restrictions
- •Restricted Oxalate Diet
- •Conservative Measures
- •Selective Medical Therapy
- •Absorptive Hypercalciuria
- •Thiazide
- •Orthophosphate
- •Renal Hypercalciuria
- •Primary Hyperparathyroidism
- •Hyperuricosuric Calcium Oxalate Nephrolithiasis
- •Enteric Hyperoxaluria
- •Hypocitraturic Calcium Oxalate Nephrolithiasis
- •Distal Renal Tubular Acidosis
- •Chronic Diarrheal States
- •Thiazide-Induced Hypocitraturia
- •Idiopathic Hypocitraturic Calcium Oxalate Nephrolithiasis
- •Hypomagnesiuric Calcium Nephrolithiasis
- •Gouty Diathesis
- •Cystinuria
- •Infection Lithiasis
- •Summary
- •References
- •12: Molecular Biology for Urologists
- •Introduction
- •Inherited Changes in Cancer Cells
- •VEGR and Cell Signaling
- •Targeting mTOR
- •Conclusion
- •References
- •13: Chemotherapeutic Agents for Urologic Oncology
- •Introduction
- •Bladder Cancer
- •Muscle Invasive Bladder Cancer
- •Metastatic Bladder Cancer
- •Conclusion
- •Prostate Cancer
- •Other Chemotherapeutic Drugs or Combinations for Treating HRPC
- •Conclusion
- •Renal Cell Carcinoma
- •Chemotherapy
- •Immunotherapy
- •Angiogenesis Inhibitor Drugs
- •Conclusion
- •Testicular Cancer
- •Stage I Seminoma
- •Stage I non-seminomatous Germ Cell Tumours (NSGCT)
- •Metastatic Germ Cell Tumours
- •Low-Volume Metastatic Disease (Stage II A/B)
- •Advanced Metastatic Disease
- •Salvage Chemotherapy for Relapsed or Refractory Disease
- •Conclusion
- •Penile Cancer
- •Side Effects of Chemotherapy
- •Conclusion
- •References
- •14: Tumor and Transplant Immunology
- •Antibodies
- •Cytotoxic and T-helper Cells
- •Immunosuppression
- •Induction Therapy
- •Maintenance Therapy
- •Rejection
- •Posttransplant Lymphoproliferative Disease
- •Summary
- •References
- •15: Pathophysiology of Renal Obstruction
- •Causes of Renal Obstruction
- •Effects on Prenatal Development
- •Prenatal Hydronephrosis
- •Spectrum of Renal Abnormalities
- •Renal Functional Changes
- •Renal Growth/Counterbalance
- •Vascular Changes
- •Inflammatory Mediators
- •Glomerular Development Changes
- •Mechanical Stretch of Renal Tubules
- •Unilateral Versus Bilateral
- •Limitations of Animal Models
- •Future Research
- •Issues in Patient Management
- •Diagnostic Imaging
- •Ultrasound
- •Intravenous Urography
- •Antegrade Urography and the Whitaker Test
- •Nuclear Renography
- •Computed Tomography
- •Magnetic Resonance Urography
- •Hypertension
- •Postobstructive Diuresis
- •References
- •Introduction
- •The Normal Lower Urinary Tract
- •Anatomy
- •Storage Function
- •Voiding Function
- •Neural Control
- •Symptoms
- •Flow Rate and Post-void Residual
- •Voiding Cystometry
- •Male
- •Female
- •Neurourology
- •Conclusions
- •References
- •17: Urologic Endocrinology
- •The Testis
- •Normal Androgen Metabolism
- •Epidemiological Aspects
- •Prostate
- •Brain
- •Muscle Mass and Adipose Tissue
- •Bones
- •Ematopoiesis
- •Metabolism
- •Cardiovascular System
- •Clinical Assessment
- •Biochemical Assessment
- •Treatment Modalities
- •Oral Preparations
- •Parenteral Preparations
- •Transdermal Preparations
- •Side Effects and Treatment Monitoring
- •Body Composition
- •Cognitive Decline
- •Bone Metabolism
- •The Kidneys
- •Endocrine Functions of the Kidney
- •Erythropoietin
- •Calcitriol
- •Renin
- •Paraneoplastic Syndromes
- •Hypercalcemia
- •Hypertension
- •Polycythemia
- •Other Endocrine Abnormalities
- •References
- •General Physiology
- •Prostate Innervation
- •Summary
- •References
- •Wound Healing
- •Inflammation
- •Proliferation
- •Remodeling
- •Principles of Plastic Surgery
- •Tissue Characteristics
- •Grafts
- •Flap
- •References
- •Lower Urinary Tract Symptoms
- •Storage Phase
- •Voiding Phase
- •Return to Storage Phase
- •Urodynamic Parameters
- •Urodynamic Techniques
- •Volume Voided Charts
- •Pad Testing
- •Typical Test Schedule
- •Uroflowmetry
- •Post Voiding Residual
- •Further Diagnostic Evaluation of Patients
- •Cystometry with or Without Video
- •Cystometry
- •Videocystometrography (Cystometry + Cystourethrography)
- •Cystometric Findings
- •Comment:
- •Measurements During the Storage Phase:
- •Measurements During the Voiding Phase:
- •Abnormal Function
- •Disorders of Sensation
- •Causes of Hypersensitive Bladder Sensation
- •Causes of Hyposensitive Bladder Sensation
- •Disorders of Detrusor Motor Function
- •Bladder Outflow Tract Dysfunction
- •Detrusor–Urethral Dyssynergia
- •Detrusor–Bladder Neck Dyssynergia
- •Detrusor–Sphincter Dyssynergia
- •Complex Urodynamic Investigation
- •Urethral Pressure Measurement
- •Technique
- •Neurophysiological Evaluation
- •Conclusion
- •References
- •Endoscopy
- •Cystourethroscopy
- •Ureteroscopy and Ureteropyeloscopy
- •Nephroscopy
- •Virtual Reality Simulators
- •Lasers
- •Clinical Application of Lasers
- •Condylomata Acuminata
- •Urolithiasis
- •Benign Prostatic Hyperplasia
- •Ureteral and Urethral Strictures
- •Conclusion
- •References
- •Introduction
- •The Prostatitis Syndromes
- •The Scope of the Problem
- •Category III CP/CPPS
- •The Goal of Treatment
- •Conservative Management
- •Drug Therapy
- •Antibiotics
- •Anti-inflammatories
- •Alpha blockers
- •Hormone Therapies
- •Phytotherapies
- •Analgesics, muscle relaxants and neuromodulators
- •Surgery
- •A Practical Management Plan
- •References
- •Orchitis
- •Definition and Etiology
- •Clinical Signs and Symptoms
- •Diagnostic Evaluation
- •Treatment of Infectious Orchitis
- •Epididymitis
- •Definition and Etiology
- •Clinical Signs and Symptoms
- •Diagnostic Evaluation of Epididymitis
- •Treatment of Acute Epididymitis
- •Treatment of Chronic Epididymitis
- •Treatment of Spermatic Cord Torsion
- •Fournier’s Gangrene
- •Definition and Etiology
- •Risk Factors
- •Clinical Signs and Symptoms
- •Diagnostic Evaluation
- •Treatment
- •References
- •Fungal Infections
- •Candidiasis
- •Aspergillosis
- •Cryptococcosis
- •Blastomycosis
- •Coccidioidomycosis
- •Histoplasmosis
- •Radiographic Findings
- •Treatment
- •Tuberculosis
- •Clinical Manifestations
- •Diagnosis
- •Treatment
- •Schistosomiasis
- •Clinical Manifestations
- •Diagnosis
- •Treatment
- •Filariasis
- •Clinical Manifestations
- •Diagnosis
- •Treatment
- •Onchocerciasis
- •References
- •25: Sexually Transmitted Infections
- •Introduction
- •STIs Associated with Genital Ulcers
- •Herpes Simplex Virus
- •Diagnosis
- •Treatment
- •Chancroid
- •Diagnosis
- •Treatment
- •Syphilis
- •Diagnosis
- •Treatment
- •Lymphogranuloma Venereum
- •Diagnosis
- •Treatment
- •Chlamydia
- •Diagnosis
- •Treatment
- •Gonorrhea
- •Diagnosis
- •Treatment
- •Trichomoniasis
- •Diagnosis
- •Treatment
- •Human Papilloma Virus
- •Diagnosis
- •Treatment
- •Scabies
- •Diagnosis
- •Treatment
- •References
- •26: Hematuria: Evaluation and Management
- •Introduction
- •Classification of Hematuria
- •Macroscopic Hematuria
- •Microscopic Hematuria
- •Dipstick Hematuria
- •Pseudohematuria
- •Factitious Hematuria
- •Menstruation
- •Aetiology
- •Malignancy
- •Urinary Calculi
- •Infection and Inflammation
- •Benign Prostatic Hyperplasia
- •Trauma
- •Drugs
- •Nephrological Causes
- •Assessment
- •History
- •Examination
- •Investigations
- •Dipstick Urinalysis
- •Cytology
- •Molecular Tests
- •Blood Tests
- •Flexible Cystoscopy
- •Upper Urinary Tract Evaluation
- •Renal USS
- •KUB Abdominal X-Ray
- •Intravenous Urography (IVU)
- •Computed Tomography (CT)
- •Retrograde Urogram Studies
- •Magnetic Resonance Imaging (MRI)
- •Additional Tests and Renal Biopsy
- •Intractable Hematuria
- •Loin Pain Hematuria Syndrome
- •References
- •27: Benign Prostatic Hyperplasia (BPH)
- •Historical Background
- •Pathophysiology
- •Patient Assessment
- •Treatment of BPH
- •Watchful Waiting
- •Drug Therapy
- •Interventional Therapies
- •Conclusions
- •References
- •28: Practical Guidelines for the Treatment of Erectile Dysfunction and Peyronie´s Disease
- •Erectile Dysfunction
- •Introduction
- •Diagnosis
- •Basic Evaluation
- •Cardiovascular System and Sexual Activity
- •Optional Tests
- •Treatment
- •Medical Treatment
- •Oral Agents
- •Phosphodiesterase Type 5 (PDE 5) Inhibitors
- •Nonresponders to PDE5 Inhibitors
- •Apomorphine SL
- •Yohimbine
- •Intracavernosal and Intraurethral Therapy
- •Intracavernosal Injection (ICI) Therapy
- •Intraurethral Therapy
- •Vacuum Constriction Devices
- •Surgical Therapy
- •Conclusion
- •Peyronie´s Disease (PD)
- •Introduction
- •Oral Drug Therapy
- •Intralesional Drug Therapy
- •Iontophoresis
- •Radiation Therapy
- •Surgical Therapy
- •References
- •29: Premature Ejaculation
- •Introduction
- •Epidemiology
- •Defining Premature Ejaculation
- •Voluntary Control
- •Sexual Satisfaction
- •Distress
- •Psychosexual Counseling
- •Pharmacological Treatment
- •On-Demand Treatment with Tramadol
- •Topical Anesthetics
- •Phosphodiesterase Inhibitors
- •Surgery
- •Conclusion
- •References
- •30: The Role of Interventional Management for Urinary Tract Calculi
- •Contraindications to ESWL
- •Complications of ESWL
- •PCNL Access
- •Instrumentation for PCNL
- •Nephrostomy Drains Post PCNL
- •Contraindications to PCNL
- •Complications of PCNL
- •Semirigid Ureteroscopy
- •Flexible Ureteroscopy
- •Electrohydraulic Lithotripsy (EHL)
- •Ultrasound
- •Ballistic Lithotripsy
- •Laser Lithotripsy
- •Ureteric Stents
- •Staghorn Calculi
- •Lower Pole Stones
- •Horseshoe Kidneys and Stones
- •Calyceal Diverticula Stones
- •Stones and PUJ Obstruction
- •Treatment of Ureteric Colic
- •Medical Expulsive Therapy (MET)
- •Intervention for Ureteric Stones
- •Stones in Pregnancy
- •Morbid Obesity
- •References
- •Anatomy and Function
- •Pathophysiology
- •Management
- •Optical Urethrotomy/Dilatation
- •Urethral Stents
- •Preoperative Assessment
- •Urethroplasty
- •Anastomotic Urethroplasty
- •Substitution Urethroplasty
- •Grafts Versus Flaps
- •Oral Mucosal Grafts
- •Tissue Engineering
- •Graft Position
- •Conclusion
- •References
- •32: Urinary Incontinence
- •Epidemiology and Risk Factors
- •Pathophysiology
- •Urge Incontinence
- •Conservative Treatments
- •Pharmacotherapy
- •Invasive/ Surgical Therapies
- •Stress Urinary Incontinence
- •Male SUI Therapies
- •Female SUI Therapies
- •Mixed Urinary Incontinence
- •Conclusions
- •References
- •33: Neurogenic Bladder
- •Introduction
- •Examination and Diagnostic Tests
- •History and Physical Examination
- •Imaging
- •Urodynamics (UDS)
- •Evoked Potentials
- •Classifications
- •Somatic Pathways
- •Brain Lesions
- •Cerebrovascular Accident (CVA)
- •Parkinson’s Disease (PD)
- •Multiple Sclerosis
- •Huntington’s Disease
- •Dementias
- •Normal Pressure Hydrocephalus (NPH)
- •Tumors
- •Psychiatric Disorders
- •Spinal Lesions and Pathology
- •Intervertebral Disk Prolapse
- •Spinal Cord Injury (SCI)
- •Transverse Myelitis
- •Peripheral Neuropathies
- •Metabolic Neuropathies
- •Pelvic Surgery
- •Treatment
- •Summary
- •References
- •34: Pelvic Prolapse
- •Introduction
- •Epidemiology
- •Anatomy and Pathophysiology
- •Evaluation and Diagnosis
- •Outcome Measures
- •Imaging
- •Urodynamics
- •Indications for Management
- •Biosynthetics
- •Surgical Management
- •Anterior Compartment Repair
- •Uterine/Apical Prolapse
- •Enterocele Repair
- •Conclusion
- •References
- •35: Urinary Tract Fistula
- •Introduction
- •Urogynecologic Fistula
- •Vesicovaginal Fistula
- •Etiology and Risk Factors
- •Clinical Factors
- •Evaluation and Diagnosis
- •Pelvic Examination
- •Cystoscopy
- •Imaging
- •Treatment
- •Conservative Management
- •Surgical Management
- •Urethrovaginal Fistula
- •Etiology and Presentation
- •Diagnosis and Management
- •Ureterovaginal Fistula
- •Etiology and Presentation
- •Diagnosis and Management
- •Vesicouterine Fistula
- •Etiology and Presentation
- •Diagnosis and Management
- •Uro-Enteric Fistula
- •Vesicoenteric Fistula
- •Pyeloenteric Fistula
- •Urethrorectal Fistula
- •References
- •36: Urologic Trauma
- •Introduction
- •Kidney
- •Expectant Management
- •Endovascular Therapy
- •Operative Intervention
- •Operative Management: Follow-up
- •Reno-Vascular Injuries
- •Pediatric Renal Injuries
- •Adrenal
- •Ureter
- •Diagnosis
- •Treatment
- •Delayed Diagnosis
- •Bladder and Posterior Urethra
- •Bladder Injuries: Initial Management
- •Bladder Injuries: Formal Repair
- •Anterior Urethral Trauma
- •Fractured Penis
- •Penile Amputation
- •Scrotal and Testicular Trauma
- •Imaging
- •CT-IVP (CT with Delayed Images)
- •Technique
- •Cystogram
- •Technique
- •Retrograde Urethrogram (RUG)
- •Technique
- •Retrograde Pyelogram (RPG)
- •Technique
- •One-Shot IVP
- •Technique
- •References
- •37: Bladder Cancer
- •Who Should Be Investigated?
- •Epidemiology
- •Risk Factors
- •Role of Screening
- •Signs and Symptoms
- •Imaging
- •Cystoscopy
- •Urine Tests
- •PDD-Assisted TUR
- •Pathology
- •NMIBC and Risk Groups
- •Intravesical Chemotherapy
- •Intravesical Immunotherapy
- •Immediate Cystectomy and CIS
- •Radical Cystectomy with Pelvic Lymph Node Dissection
- •sexual function-preserving techniques
- •Bladder-Preservation Treatments
- •Neoadjuvant Chemotherapy
- •Adjuvant Chemotherapy
- •Preoperative Radiotherapy
- •Follow-up After TUR in NMIBC
- •References
- •38: Prostate Cancer
- •Introduction
- •Epidemiology
- •Race
- •Geographic Variation
- •Risk Factors and Prevention
- •Family History
- •Diet and Lifestyle
- •Prevention
- •Screening and Diagnosis
- •Current Screening Recommendations
- •Biopsy
- •Pathology
- •Prognosis
- •Treatment of Prostate Cancer
- •Treatment for Localized Prostate Cancer (T1, T2)
- •Radical Prostatectomy
- •EBRT
- •IMRT
- •Brachytherapy
- •Treatment for Locally Advanced Prostate Cancer (T3, T4)
- •EBRT with ADT
- •Radical Prostatectomy
- •Androgen-Deprivation Therapy
- •Summary
- •References
- •39: The Management of Testis Cancer
- •Presentation and Diagnosis
- •Serum Tumor Markers
- •Primary Surgery
- •Testis Preserving Surgery
- •Risk Stratification
- •Surveillance Versus Primary RPLND
- •Primary RPLND
- •Adjuvant Treatment for High Risk
- •Clinical Stage 1 Seminoma
- •Risk-Stratified Adjuvant Treatment
- •Adjuvant Radiotherapy
- •Adjuvant Low Dose Chemotherapy
- •Primary Combination Chemotherapy
- •Late Toxicity
- •Salvage Strategies
- •Conclusion
- •References
- •Index
419
cUrrEnt concEPts of antErior UrEthral Pathology: ManagEMEnt and fUtUrE dirEctions
urethral stricture ranging between 1 and 3 cm in length.Above this length a substitution procedure is more likely. The etiology of a stricture has an influence on any decision since inflammatory strictures and those associated with BXO have a tendency to be longer and in the context of the latter have a tendency to recurrence because of recrudescence of the underlying disease process.
Preoperatively, one must warn the patient about the risks of the procedure mentioning; complications, failure rate, need for additional procedures, need for follow-up, and recurrence. Much is publicized about the risk of erectile dysfunction and three papers have appeared in the literature over the last decade relating to this. Coursey et al. reported in a retrospective study that in experienced hands most men who undergo anterior urethral reconstruction are no more likely to have impaired sexual function than those that undergo circumcision.21 Clearly, alterations in the penile appearance and sexual performance may occur after anterior urethroplasty,which are usually transient and more likely if the stricture is lengthy,than if it is a short stricture requiring an anastomotic procedure. Anger and colleagues supported this view suggesting that surgery had an insignificant long-term effect on erectile dysfunction and that surgical complexity made no difference to the incidences of erectile dysfunction.22 Erickson and colleagues (2006) confirmed these findings, both papers however suggesting clearly that there was an increasing risk of erectile dysfunction with increasing age and if there was a preceding history of problems.23 A prospective study has recently been reported suggesting that there is a risk of erectile dysfunction within the first few months following surgery,24 which certainly equates with our personal experience, but with time this improves and most men who develop erectile dysfunction of any sort will have full recovery by 7 months. They did note that in some men, persistence of erectile dysfunction was seen,but that long-term follow-up would be necessary before they can categorically provide advice based on this information.
Urethroplasty
The length of a urethral stricture will dictate the complexity of the necessary surgery; longer lesions require more complicated surgery. The spectrum of “urethroplasty” surgery employs the full armamentarium of plastic surgical skills. Ranging from the simplest procedure for
short strictures, an anastomotic urethroplasty, where the diseased urethral segment is excised and the two ends anastomosed together; up to a substitution urethroplasty where a longer segment of urethral lumen is replaced by a graft or flap using a oneor two-stage technique. In this chapter we will give an overview of the different techniques in practice and review the evidence base relating to their use.
Anastomotic Urethroplasty
Anastomotic urethroplasty involves excision of the stricture and primary anastomosis of the urethral ends. Traditionally, strictures less than 3 cm only were considered suitable for an anastomotic procedure. However, by freeing up the urethra and separating the corpora (Fig. 31.2a) another few centimeters may be gained in length. Morey et al. when comparing anastomotic procedures carried out for a stricture length ranging from 2.6 to 5.0 cm reported success rates of 91%, as compared to a control group with a stricture length less than 2.5 cm. However, the series only had 11 patients in each group and the mean fol- low-up period was 22 months.25 Two large series have recently been reported looking at the success rates of anastomotic urethroplasty – Santucci et al. (2002)26 and Barbagli et al. (2008),27 reporting success rates of 95% and 91%, respectively.
The procedure for anastomotic urethroplasty is detailed below: When tackling a bulbar stricture which is one of the commonest types of stricture, a midline skin incision is made in the perineum behind the scrotum.Following dissection through the superficial tissues, the bulbospongiosus muscle is exposed (Fig. 31.2b, c). Division of the bulbospongiosus muscle has been criticized recently by Barbagli et al. who describe a procedure used in 12 patients with bulbar urethral strictures where dissection of the bulbospongiosus muscle off of the corpus spongiosum was avoided, leaving the central tendon of the perineum intact.28 The majority of surgeons do not feel that it is necessary to preserve the integrity of this muscle and there is only limited expert opinion suggesting that this approach is beneficial.
Thereafter, the next step is to dissect behind the urethra between the corpus spongiosum and the corpora cavernosa, thus freeing the urethra completely (Fig. 31.2d, e). It is important to identify the exact site of the stricture, either using a sound, or as we prefer to do this using an
|
|
420 |
|
|
|
|
|
Practical Urology: EssEntial PrinciPlEs and PracticE |
endoscope to precisely identify the stricture, |
minimizing the potential for converting an anas- |
|
transilluminate its distal end with the cystoscope |
tomotic procedure into a substitution procedure |
|
and then put a stitch directly through at the dis- |
by reducing the length of the incised urethra. |
|
tal extent of the stricture. By cutting just proxi- |
In carrying out the anastomotic procedure it is |
|
mal to the suture which is placed in the stricture, |
important to spatulate the urethra extending the |
|
it is possible to transect the urethra accurately |
incision into normal tissue at both ends and to fix |
|
without any loss of normal urethra, therefore |
the proximal urethra by sutures that pass through |
|
a |
b |
c |
1 |
2 |
3 |
|
|
|
6 |
|
1 |
|
5 |
|
2 |
|
|
|
|
|
|
|
|
3 |
4 |
|
|
|
|
|
d |
|
e |
f |
|
|
|
Figure 31.2. (a) diagrammatic representation of the additional length gained by separation of the corpora cavernosa. numbers represent approximate length in centimeters (Mundy, BJUi surgical atlas) (b, c) Midline perineal incision, through the superficial tissues exposing and dividing the bulbospongiosus muscle to expose the urethra (reprinted from Mundy ar, Urodynamic and Reconstructive Surgery of the Lower Urinary Tract. copyright Elsevier, 1993) (d, e) completely freeing the urethra from the corpora cavernosa (reprinted from Mundy ar, Urodynamic and Reconstructive Surgery of the Lower Urinary Tract. copyright Elsevier,
1993) (f, g) spatulating both ends of the urethra to aid anastomosis.chapple pic,Mundy figure (g – reprinted from Mundy ar,
Urodynamic and Reconstructive Surgery of the Lower Urinary Tract. copyright Elsevier, 1993) (h, i) completion of the anastomosis, note rotation of the distal urethra by 180° (i – reprinted from Mundy ar, Urodynamic and Reconstructive Surgery of the Lower Urinary Tract. copyright Elsevier, 1993) (j) closure of the corpora cavernosa over the bulbar urethral anastomosis (reprinted from Mundy ar, Urodynamic and Reconstructive Surgery of the Lower Urinary Tract. copyright Elsevier, 1993).
421
cUrrEnt concEPts of antErior UrEthral Pathology: ManagEMEnt and fUtUrE dirEctions
Figure 31.2. (continued) |
g |
h |
|
i |
j |
the full thickness of the corpus spongiosum into the tunica albuginea of the corpora cavernosa thereby avoiding contracture at the site of the anastomosis (Fig. 31.2f, g). We usually use a size 32 F sound to check this easily passes through the anastomosis prior to closure. It is also important to bear in mind that one can rotate the distal urethra through 180° to achieve the optimal positioning of the spatulated ends during the subsequent anastomosis (Fig. 31.2h, i).
When closing the urethra we usually use a two-layer anastomosis ventrally, the outer layer should be a running suture as this is important to secure hemostasis of the corpus spongiosum. Careful closure of subcutaneous tissue planes is important to adequately occlude dead space and prevent either hematoma formation or infection from occurring; in our experience using this approach followed by a firm supporting dressing using elasticated
|
|
|
|
422 |
|
|
|
|
|
|
|
|
|
|
|
Practical Urology: EssEntial PrinciPlEs and PracticE |
|
knickers for 4 days is important as it prevents |
substitution – a so-called onlay substitution pro- |
||||
hematoma formation. We tend to leave both a |
cedure, or the third option that we would not |
||||
urethral and a suprapubic catheter for 12–14 days |
recommend is to excise the stricture and put in a |
||||
followed by a contrast study to check that the |
circumferential patch – a tube substitution. This |
||||
anastomosis is “watertight.” This is followed |
latter option is associated with a high failure rate, |
||||
by removal of the urethral catheter which is in |
which may be as high as 30%.29,30 A two-stage |
||||
turn followed by removal of the suprapubic |
procedure involves excision of the stricture and |
||||
catheter. |
|
|
the abnormal urethra and reconstruction of a |
||
It is often possible to carry out an anastomotic |
roof strip which is allowed to heal prior to sec- |
||||
urethroplasty for strictures longer than 2–3 cm. |
ond-stage tubularization. |
||||
Foreshortening of the urethral course by sepa- |
|
||||
rating the two bodies of the corpora cavernosa |
Grafts Versus Flaps |
||||
is an important maneuver since it will lead to |
|||||
straightening of the natural curve of the bulbar |
Prior controversy existed in the field relating to |
||||
urethra and allow an additional 2–4 cm in length |
|||||
whether one should use a graft or flap, but it is |
|||||
depending on local circumstances (Fig. 31.2a). |
|||||
now clearly established from a review of the lit- |
|||||
Closure of the urethra can then be accomplished |
|||||
erature that the re-stenosis rate recorded in the |
|||||
in a standard fashion. The corpora cavernosa |
|||||
published literature in 1998 was between 14.5% |
|||||
can be closed over the bulbar urethral anasto- |
|||||
and 15.7% using either a flap or graft, respec- |
|||||
mosis (Fig. 31.2l). Clearly, the amount of length |
|||||
tively.31 It can therefore be concluded that there |
|||||
that can be gained will |
depend upon |
the |
|||
is no advantage of a graft over a flap in terms of |
|||||
anatomical circumstances |
depending on |
the |
|||
re-stenosis rate. Indeed Dubey in a small com- |
|||||
anatomy of any individual male and this is pro- |
|||||
parative randomized study confirmed there to |
|||||
portional to the length and the elasticity of the |
|||||
be equivalence in terms of success with the two |
|||||
distal urethral segment, and in particular the |
|||||
techniques but with higher morbidity for the |
|||||
size of the penis and urethra itself. As we men- |
|||||
patients using a flap procedure.32 |
|||||
tioned earlier, it is now clearly established that |
|||||
In carrying out a substitution procedure, one |
|||||
anastomotic urethroplasty in the bulbar urethra |
|||||
has to also consider whether full thickness tis- |
|||||
in experienced hands is associated with a suc- |
|||||
sue or partial thickness tissue is used. The |
|||||
cess rate of up to 95%.26,27 |
|
|
|||
|
|
|
|
importance of this is that partial thickness tis- |
|
|
|
|
|
sue has a greater propensity to contract than full |
|
Substitution Urethroplasty |
|
thickness tissue. |
|||
|
|
|
|
The number of therapeutic options which |
|
The factors limiting the potential for using anas- |
have been suggested in the past include scrotal |
||||
tomotic urethroplasty are the length of the stric- |
skin,33 extragenital skin,34 bladder mucosa,35 |
||||
ture and anatomical considerations. One cannot |
and colonic mucosa.36 In contemporary prac- |
||||
simply excise a stricture and restore continuity |
tice, genital skin or oral mucosa are most com- |
||||
as in the gut, because of the potential for causing |
monly used, although there is interest in the |
||||
a chordee; in fact, it is a useful rule that the bul- |
future in the potential for tissue engineering.37 |
||||
bar urethra should not be mobilized distal to the |
Genital skin flaps are particularly useful when |
||||
penoscrotal junction and therefore if the stric- |
dealing with strictures in the penile urethra |
||||
ture is lengthy it may be necessary to carry out a |
where an onlay flap of penile skin can be par- |
||||
substitution procedure. Similarly, it is very |
ticularly helpful. However, bear in mind that the |
||||
uncommon except in the context of a very lim- |
use of penile skin in this context is contraindi- |
||||
ited traumatic injury of the penile urethra such |
cated if there is any suggestion that BXO is pres- |
||||
as seen with penile rupture injuries to be able to |
ent which tends to recur in skin (either genital |
||||
carry out an anastomotic urethroplasty in the |
or extragenital in origin). Furthermore, Blandy |
||||
penile urethra. A substitution procedure could |
et al. found a scrotal pull through procedure to |
||||
be either a one-stage or a two-stage procedure. |
have a high incidence of complications38 and to |
||||
There are three potential options with a one- |
his credit at the end of his career reported on the |
||||
stage procedure; to excise the stricture and |
significant morbidity, in the longer term, associ- |
||||
restore a roof strip of native urethra augmented |
ated with the use of scrotal skin. Scrotal skin in |
||||
by a patch – an augmented anastomotic proce- |
our view should not be used except in excep- |
||||
dure, to incise the stricture and carry out a patch |
tional circumstances. |
423
cUrrEnt concEPts of antErior UrEthral Pathology: ManagEMEnt and fUtUrE dirEctions
A number of different types of flap have been described over the years and these vary in terms of their orientation and whether they have bilateral or unilateral pedicles (Fig. 31.3a–d).A number of eponymous names based on the authors who reported them have been utilized to describe the contemporary flaps which are recognized. We would suggest a more pragmatic approach. When considering a flap, firstly identify an area of hairless penile skin (it is important not to allow the patient to be shaved before coming to the operating room) of adequate length to reconstruct the urethral defect. Next,
based on the anatomy of the penis, decide the configuration of the flap, that is, transverse, longitudinal, oblique, etc. Next, determine how to obtain adequate subcutaneous tissue –using a bilateral or unilateral pedicle. Remember that the skin is a “passenger” on the subcutaneous tissues. Ventral onlay skin flaps are particularly useful in the management of penile strictures due to etiologies other than BXO.
When considering the bulbar urethra, the current recognized standard of care is to use a graft in the majority of cases, since the efficacy of grafts and flaps appears to be very similar.39
a |
b |
c |
d |
Figure 31.3. (a–d) Various flaps utilized in urethroplasty.
|
|
424 |
|
|
|
|
|
Practical Urology: EssEntial PrinciPlEs and PracticE |
A randomized controlled trial carried out by |
(Fig. 31.4a), skin necrosis (Fig. 31.4b), fistula |
|
Dubey, showed that the efficacy of both grafts |
formation (Fig. 31.4c), and if one is using a dis- |
|
and flaps was identical, but there was a much |
tal flap derived from the prepuce, penile and |
|
higher morbidity with penile skin flaps which |
glans torsion (Fig. 31.4d). In the longer term, |
|
were also technically more complex and less |
flaps are associated with a higher propensity to |
|
likely to be preferred by patients because of the |
sacculation formation in the substitution |
|
morbidity.32 Indeed it is well recognized that a |
(Fig. 31.4e, f). |
|
number of complications can occur following |
Barbagli and colleagues have reviewed their |
|
flap urethroplasty including penile hematoma |
experience using dorsal onlay skin graft |
|
|
a |
b |
c |
d |
e |
f |
Figure 31.4. (a–f) complications of flap urethroplasty. (a) hematoma, (b) skin necrosis, (c) fistula, (d) glans torsion, (e, f) sacculation. (a–d – courtesy of guido Barbagli).